ABSTRACT
INTRODUCTION
Malaria still remains a serious disease with high mortality and morbidity especially in children and pregnant women with the Sub-Saharan Africa bearing the highest burden of the disease (WHO 2010) . Due to the absence of an approved vaccine for use in the control of malaria, chemotherapy remains an effective intervention against the scourge of the disease. The spate of drug resistance by the etiologic parasites particularly P. falciparum among others to several drugs particularly chloroquine had necessitated the scientific evaluation of many traditional medicinal plants for alternative antimalarial drugs (Oyedeji et al., 2005) particularly from plants as earlier antimalarial drugs were derived from compounds obtained from herbal plants used in treating fevers including malaria. Many plants are used in the traditional system as antimalarials especially in Africa (World Health Organisation, WHO / Tropical Disease Research TDR news, 2007 and Hostettmann et al., 2000) . It is for this reason that some plants used in the traditional treatment of malaria or fever by the Hausa people of Kano, Nigeria were selected and evaluated for efficacy against the Plasmodium parasite in vivo. The in vitro antiplasmodial activities of extracts from these plants against laboratory adapted chloroquine susceptible strain of Plasmodium falciparum (3D7) were earlier reported (Dabo et al. Fresh plant materials were collected and shade dried to minimize deterioration of active components. Each dried plant material was then ground into powder using mortar and pestle. Two hundred and fifty grams (250g) portions were then weighed out and extracted im accordance with Fatope et al. (1993) by percolating in absolute ethanol (Rjedel-de Haȅn®) at 1:5 w/v (plant part: solvent) for two weeks and filtered using Whatman® No.1 filter paper. A portion of the extract was transferred into pre-weighed specimen bottle and designated F1. The four plant leaves used as combination (M. Indica, C. Papaya, P. guajava and C, aurantifolia) were prepared by weighing equal proportions of the respective plants (12.5g each). Four extracts which exhibited appreciable inhibitory activities in vitro against the laboratory reared strain of chloroquine susceptible P. falciparum (Dabo et. al., 2013) were thus evaluated for in vivo activity against a rodent malaria parasite P. berghei. These comprised of A. nilotica stem extract (designated as ANSF1); C. aurantifolia leaf extract (designated as CALF1); M. indica leaf extract (designated as MILF1) and combination of C. aurantifolia, C. papaya, M. indica and P. guajava leaves extract (designated as CBLF1).
Evaluation of Antiplasmodial Activity on Early Infection
The Knight and Peters (1980) 4-day suppressive test for evaluating parasitaemia in early infection was employed (Chandel and Bagai, 2010; Matur et al., 2009) . Animal model for the in vivo study were icr mice obtained from the Animal Experimentation Department, Noguchi Memorial Institute of Medical Research, NMIMR University of Ghana, Legon. These were acclimatized in the laboratory for 5 days prior to the commencement of the experiment with food and water provided ad libitum. P. berghei, a rodent malaria parasite obtained from the Immunology Department, NMIMR was used for the evaluation. The parasites were stabilised by continuous re-infection in recipient mice by passaging with 200µL of normal saline diluted parasites through intraperitoneal route (David et al., 2004; Peter and Anatoli, 1998 ) using a 26G needle and 1mL Terumo® syringe. Parasitaemia was allowed to build-up for three days, after which blood smears were made, by taking blood obtained from tail snips of the mouse, to assess the level of parasitaemia before another passage was done.
Once 30-40 % parasitaemia was attained in the donor mouse, it was anaethesised under chloroform. Following the technique of Hoff, (2000), 0.5ml of blood was drawn by cardiac puncture from it and transferred into a screw capped sterile plastic tube and then topped up to14 ml with normal saline. This served as the inoculums for the in vivo assay. Thirty six (36) experimental icr mice were then injected intra-peritoneally (ip) with 0.2ml of the suspension (Innocent et al., 2009; Jigam et al., 2009 ) and randomly assigned into 5 treatment groups of six mice per group. Twenty four (24) hours after inoculation and infection confirmed, the extracts were administered via oral gavage at dose levels of 100 mg/kg body weight daily for 4 days using 1 ml syringe fitted with a trachea needle ( Table 2 below) . Artesunate was however administered to the fifth group at the dose of 1.6 mg/kg body weight for 4 days. A sixth and seventh groups of mice with neither plant extract no artesunate served as the control II group. The control II group was given normal saline. A set of mice which had neither infection nor treatment were also maintained along the experimental sets. These were designated control I group. Further evaluation of the most potent plant extract CALF1 at the same concentration as mentioned above was carried out alongside artesunate and di-methylsulfoxide (DMSO) following the protocol explained above on 3 groups of the icr mice. This was aimed at confirming the earlier observation and to ascertain the noninterference of the DMSO diluent used for the extract on the P. berghei and hence the result of the experiment in general.
Determination of Parasitaemia
Parasitaemia in experimental mice in all groups was monitored by Giemsa-stained thin blood films (WHO (1991) obtained from tail snips of the mice in all the groups (Ene, et al. 2009; Lamb and Langhorne 2008) starting from day 1, (24hours) after inoculation of parasites until the sixth day. At least five hundred uninfected RBCs were counted against the infected to determine percent parasitaemia. Percentage suppression of parasitaemia was then calculated using values from control animals using the relation:
Where a = average % Parasitaemia in control groups, b= average % parasitaemia in extract or artesunate. Parasite density was expressed as number of parasite per 200 white blood cells x 8000 (Greenwood and Armstrong 1991) .
Measurement of Body Weight
Body weights of mice were measured on D0 (the 1 st day of the commencement of the experiment) and D7 (the 7 th day of the commencement of the experiment)
as described by Dikasso et al, (2006) , using TOLEDO® Metler Balance (Japan), to observe whether the test prevented the weight loss that is common with increasing parasitaemia in infected mice.
Daily Measurement of (Body) Rectal Temperature Body temperature, of the mice was measured rectally daily for six days starting from the day prior to parasite inoculation. This was achieved by inserting the round tip of a digital thermometer into the anus of the mouse until a beeping sound was heard to signal the reading was confirmed.
Haematogram of Study Mice
This was achieved using terminal blood collected from fully anesthetized mice taken out via a cardiac puncture into ethylenediamine tetra-acetic acid, (EDTA) tubes as described by Hoff (2000) . This was then gently and thoroughly mixed to prevent clotting and blood cells disintegration. Haematogram of control and treated mice were achieved using Sysmex KX -2IN automated haematology analyzer (Baars, 2010) . RESULTS
In vivo Antiplasmodial Activities of Selected Extracts Body Temperature Recordings
Control I group (mice that had not been infected nor treated with any substance) had the highest mean body temperature of 34.95±0.48°C (Figure 1 ). CALF1 treatment group had the lowest mean body temperature of 33.39±0.31°C. There was a mean drop in temperature in all the infected mice ranging from 0.15°C to 1.56°C in the treated group. Statistical analysis of the data also confirmed there was significant difference (P < 0.05; P=0.0118) in the mean body temperatures of the experimental mice. Temperatures recorded for the control I group, the control II and artesunate treated groups were similar but different with that of mice in the four extract treated groups ( Figure. (Table 3) Legend: Values are means± standard error of the means; n = initial number of animals in a group.** mice that had been infected but not treated; ANSF1 = Acacia nilotica (Fabaceae) stem extract; CALF1 = Citrus aurantifolia (Rutaceae) leaf extract; MILF1 = Mangifera indica (Anacardiaceae) leaf extract; CBLF1 = Combination of C. aurantifolia, Carica papaya (Caricaceae), M. indica and Psidium guajava (Myrtaceae) leaves extract All values were compared with each others on days 0, and 3 at P = 0.05; Values with different superscripts vertically differ statistically (P < 0.05)
Daily Parasitaemia Levels after Treatment
Generally, parasitaemia increased in all the groups after the four day treatment period (Table 4) . Percent (%) parasitaemia on the 6 th day were significantly different with one another with respect to the treatments. It was lowest in the artesunate treated group (15.98±2.34 a ), followed by the CALF1 treated group (34.44±7.6 ab ). Values are means± standard error of the means; n = initial number of animals in a group. ** Mice that had been infected but not treated; ANSF1 = Acacia nilotica (Fabaceae) stem extract; CALF1 = Citrus aurantifolia (Rutaceae) leaf extract; MILF1 = Mangifera indica (Anacardiaceae) leaf extract; CBLF1 = Combination of C. aurantifolia, Carica papaya (Caricaceae), M. indica and Psidium guajava (Myrtaceae) leaves extract; Values were compared with each others on day 6 at P = 0.05; Values with different superscripts vertically differ statistically (P < 0.05)
Daily (%) Parasitaemia Suppression
Daily (%) suppression of parasitaemia levels ( Figure  3 ) in artesunate treated group yielded a suppression of 42% on day 1. This increased to 91% on day 4 of the treatment days. Percentage suppression however gradually dropped to 68.01% by the sixth day. CALF1 produced a suppression of 32.11% on day 2 and the suppression fluctuated and finally dropped to 31.06% by the 6 th day. ANSF1 however produced an initial suppression of 11.71% on day 4, which increased to 26.35 and then dropped to 16.35% on the 6 th day. CBLF1 exhibited 18.18% suppression on day 2 and increased to 25.16% by the 6 th day. MILF1 however exhibited no parasite suppression throughout the period of the experiment. 
DMSO Treated icr Mice
Mean daily parasite densities in CALF1 extract treated icr mice in relation to artesunate and Dimethyl sulfoxide, DMSO treated set further confirm the potency of CALF1 extract. The parasite densities on Day 1 were not statistically different from one another in all the treatment groups (P > 0.05; P=0.7367).
However, on Day 4, the parasite densities became significantly different among the treatments groups (P< 0.05; P=0.0075). The group treated with DMSO recorded the highest parasite density which increased steadily from Day 3 (15,836 parasite/ml) to Day 7 at about 96 000 parasite/ml (Figure 4) . The parasite densities in both artesunate and CALF1 treated groups for both day 4 and 7 were not statistically different. 
Mice Survival in Control and Treated Groups
All mice (100%) in the control group I survived the period of the experiment ( Figure 5 ). Similarly, all (100%) the parasite inoculated mice in the artesunate treated group survived during the experimental period. Percent survival of parasite infected mice was 67%. Fifty percent (50 %) of the mice in the CALF1 and CBLF1 group survived the experimental period, while only 1 survived to the seventh day in the MILF1 extract treated group. Twenty five or 60% of the 42 mice used survived the experimental period. Figure 5 : Survival of icr mice in control and Experimental Groups Infected with P. berghei LEGEND ANSF1 = Acacia nilotica (Fabaceae) stem extract; CALF1 = Citrus aurantifolia (Rutaceae) leaf extract; MILF1 = Mangifera indica (Anacardiaceae) leaf extract; CBLF1 = Combination of C. aurantifolia, Carica papaya (Caricaceae), M. indica and Psidium guajava (Myrtaceae) leaves extract * mice that had not been infected nor treated with any substance; ** mice that had been infected but not treated
Haematological Analysis
Analysis of haematological parameters (cardiac blood) in the experimental mice i are presented in Table 5 below. The highest haematocrit (%) was measured in the mice in control group I (55%) and the lowest was found in the mice treated with the MILF1 (15%). Haemoglobin was highest in mice in the control I group (13.92±0.4 g/dL) and the lowest was again found among the group treated with MILF1 (3.7±0.0 g/dL). The group of mice treated with CALF1 recorded the highest number of lymphocyte of 9, 733/µL of blood with the lowest number being recorded by the control group I (2,485/µL). Mixed granulocytes (basophils and eosinophils) and neutrophil granulocytes were only detected in the control I group and the DMSO treated mice. Mean platelets counts were highest in mice in the control group I (1,123,500/µl), closely followed by mice in the MILF1 treated group (1,181,000±0.0/µl). The least amount of platelets /µ was observed in mice in the control group II (295,750/µl).
Highest mean RBC counts of 8,226,666/µl and 7,268 ,000/µl were found among mice in the control group I and the DMSO treated groups respectively; while the least count of 2,314,444/µl was found among the mice treated with MILF1. The highest mean WBC count of 24,650/µl was found among the ANSF1 treatment group and the lowest was found among the control group I (5,066/µl). All the haematological parameters were not statistically different except haemoglobin which had a p-value of p=0.0363. Jutamaad et al., (1998) . The drop in temperature in the artesunate group was minimal and points to the efficiency of artesunate in suppressing the P. berghei parasitaemia in vivo. The assay of the artesunate and CALF1 indicated no significant difference between the treatments ((P < 0.05)). The activities exhibited by CALF1 (Rutaceae) ANSF1
(Fabaceae) and CBLF1 (a combination) in the in vivo assay corroborates the in vitro activity reported earlier (Dabo et al., 2013) . The result for CBLF1 suggests the synergistic effects of the constituent plants in CBLF1, (M. indica, C. papaya, P. guajava and C. aurantifolia).
Premature destruction of RBCs during the course of malaria infection (Claire et al. 2004; Rowe et al. 2009; Pasvol, 1986 ) is a very good index for anaemia (Dikasso, 2006) . The value obtained for all the P. berghei infected groups were found to be appreciably below the normal. This is consistent with Dikasso (2006) assertion that as 'parasite count increased haematocrit decreased'. Reduction in the leukocyte count is attributed to hypersplenism or sequestration in the spleen (Claire et al. 2004 ). The results obtained in this work indicated that the relatively low WBC count (5066±537/µl) in the control group mice and higher (8933±1969/µl to 24650±5650/µl) in the other groups is consistent with Claire et al. (2004) and
Patients Against Lymphoma, P.A.L. (2011), that increased leukocyte count indicates severe infection. The absence of the neutrophil granulocytes and the mixed granulocytes (i.e. basophils, eosinophils and monocytes) as well as the observed elevation of lymphocytes is consistent with the occurrence of malaria induced changes in the differential white cell counts associated with human malaria due to P. falciparum (Taylor, 2008) .
Thrombocytopenia which is an index of severe infection (Claire et al. 2004 ) including falciparum malaria (Maina et al., 2010) had been observed in all the experimental icr mice except MILF1 group.
It is noteworthy that the DMSO control group suffered the highest degree of thrombocytopenia. It may therefore be inferred that DMSO used may have some impact on this phenomenon. Weight loss was worse in the control group II mice (icr mice infected with p. berghei but not treated), compared to other groups.
This may suggest bioactivity effects of these extracts in reducing the weight loss associated with malaria. CONCLUSION The activities exhibited by CALF1 (Rutaceae), CBLF1 (a combination) and ANSF1 (Fabaceae),) when evaluated against P. berghei, in vivo using icr mice as animal model establishes the bio-availability and antiplasmodial activities of the active substances in the extracts evaluated and is consistent with the observed in vitro reported earlier by Dabo, et al., (2013) .
